Saturday, December 7, 2019

Two New Drugs Help Relieve Sickle-Cell Disease. But Who Will Pay? by GINA KOLATA


By GINA KOLATA

Adakveo and Oxbryta could be revolutionary treatments, but each costs about $100,000 per year and must be taken for life.

Published: December 6, 2019 at 07:00PM

from NYT Health https://ift.tt/3520H25
via IFTTT



from WordPress https://ift.tt/2RsxGIS
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)